Literature DB >> 3086593

Interaction of oral phenytoin with enteral feedings.

J J Saklad, R H Graves, W P Sharp.   

Abstract

A 48-yr-old man with squamous cell carcinoma of the lung, hypercalcemia, and brain metastases with seizures was treated with phenytoin. Constant nasogastric infusion with Osmolyte was begun for hydration and nutritional status, necessitating an increase in his phenytoin dosage. Adequate seizure control and phenytoin levels were obtained on this adjusted regimen. However, on the 16th hospital day, the patient pulled out his nasogastric tube and received two doses of phenytoin without Osmolyte. The patient became lethargic, and his phenytoin level was 53 micrograms/ml. The patient was placed on bolus nasogastric feedings and a lower dose of phenytoin administered between feedings. Adequate seizure control and appropriate phenytoin levels were obtained with no further problems. The recommended management of the phenytoin-enteral feeding interaction is to flush and clamp the nasogastric tube for 2 hr before and 2 hr after the phenytoin dose.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3086593     DOI: 10.1177/0148607186010003322

Source DB:  PubMed          Journal:  JPEN J Parenter Enteral Nutr        ISSN: 0148-6071            Impact factor:   4.016


  3 in total

1.  The bioavailability of bromazepam, omeprazole and paracetamol given by nasogastric feeding tube.

Authors:  Gregory Podilsky; Markoulina Berger-Gryllaki; Bernard Testa; Thierry Buclin; Michel Roulet; Andre Pannatier
Journal:  Eur J Clin Pharmacol       Date:  2009-02-03       Impact factor: 2.953

2.  Phenytoin absorption in volunteers receiving selected enteral feedings.

Authors:  J R Guidry; T F Eastwood; S C Curry
Journal:  West J Med       Date:  1989-06

3.  Steady-state serum phenytoin concentrations after nasogastric tube administration of immediate-release phenytoin tablets and extended-release phenytoin capsules: an open-label, crossover, clinical trial.

Authors:  Duangchit Panomvana; Napanan Khummuenwai; Supasil Sra-Ium; Somchai Towanabut
Journal:  Curr Ther Res Clin Exp       Date:  2007-09
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.